273 related articles for article (PubMed ID: 15948859)
21. Cyclosporine C2 monitoring improves renal dysfunction after lung transplantation.
Glanville AR; Morton JM; Aboyoun CL; Plit ML; Malouf MA
J Heart Lung Transplant; 2004 Oct; 23(10):1170-4. PubMed ID: 15477111
[TBL] [Abstract][Full Text] [Related]
22. Clinical benefits of neoral C2 monitoring in the long-term management of renal transplant recipients.
Cole E; Maham N; Cardella C; Cattran D; Fenton S; Hamel J; O'Grady C; Smith R
Transplantation; 2003 Jun; 75(12):2086-90. PubMed ID: 12829917
[TBL] [Abstract][Full Text] [Related]
23. Two-hour cyclosporine level determination is the appropriate tool to monitor Neoral therapy.
Cantarovich M; Besner JG; Barkun JS; Elstein E; Loertscher R
Clin Transplant; 1998 Jun; 12(3):243-9. PubMed ID: 9642517
[TBL] [Abstract][Full Text] [Related]
24. Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.
Akhlaghi F; Gonzalez L; Trull AK
J Heart Lung Transplant; 2005 Dec; 24(12):2120-8. PubMed ID: 16364860
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporine C2 target levels and acute cellular rejection after lung transplantation.
Glanville AR; Aboyoun CL; Morton JM; Plit M; Malouf MA
J Heart Lung Transplant; 2006 Aug; 25(8):928-34. PubMed ID: 16890113
[TBL] [Abstract][Full Text] [Related]
26. C2 monitoring of cyclosporine in stable renal transplant patients results in lower costs and improved renal function.
Domínguez J; Fuenzalida D; Norambuena R; Pais E; Cortes Monroy G; Llanos R
Transplant Proc; 2005 Apr; 37(3):1583-5. PubMed ID: 15866680
[TBL] [Abstract][Full Text] [Related]
27. Cyclosporine trough (C0) and 2-hour postdose (C2) levels: which one is a predictor of graft loss?
Nemati E; Einollahi B; Taheri S; Moghani-Lankarani M; Kalantar E; Simforoosh N; Nafar M; Saadat AR
Transplant Proc; 2007 May; 39(4):1223-4. PubMed ID: 17524938
[TBL] [Abstract][Full Text] [Related]
28. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ
J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255
[TBL] [Abstract][Full Text] [Related]
29. Experience with cyclosporine: approaching the therapeutic window for C2 levels in maintenance kidney transplant recipients.
Di Paolo S; Teutonico A; Infante B; Stallone G; Schena A; Grandaliano G; Battaglia M; Di Tonno P; Schena FP
Transplant Proc; 2004 Mar; 36(2 Suppl):434S-436S. PubMed ID: 15041381
[TBL] [Abstract][Full Text] [Related]
30. Cyclosporine monitoring in renal transplant recipients with induction therapy: C2 levels in patients monitored on C0.
Loichot C; Bentue-Ferrer D; Bernard N; Bonardet A; Boulieu R; Kergueris MF; Paintaud G; Peytavin G; Simon N; Marquet P;
Fundam Clin Pharmacol; 2006 Feb; 20(1):91-6. PubMed ID: 16448399
[TBL] [Abstract][Full Text] [Related]
31. Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation.
Hangler HB; Ruttmann E; Geltner C; Bucher B; Nagiller J; Laufer G; Mueller LC
Clin Transplant; 2008; 22(1):35-40. PubMed ID: 18217903
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcome after cyclosporine dose reduction based on C2 levels in long-term liver transplant patients.
Tha-In T; Hesselink DA; Tilanus HW; Elshove L; Wilschut AL; Hansen BE; van Gelder T; Metselaar HJ
Clin Transplant; 2005 Aug; 19(4):537-42. PubMed ID: 16008602
[TBL] [Abstract][Full Text] [Related]
33. Suitable whole blood levels 2 hours after neoral in liver transplant patients: experiences at a single center.
Kim KH; Lee SG; Lee YJ; Park KM; Hwang S; Ahn CS; Moon DB; Ha TY; Song KW; Kim DS; Jung DH; Kim BS; Moon KM; Lee HJ; Park JI; Ryu JH
Transplant Proc; 2006 Nov; 38(9):2971-3. PubMed ID: 17112877
[TBL] [Abstract][Full Text] [Related]
34. Single daily dose administration of cyclosporine in renal transplant recipients.
Halim MA; Said T; Al-Otaibi T; Eleawa S; Al-Maged H; Gawish AE; Nair P; Al-Muzairai I; Nampoory MR; Al-Mousawi M
Transplant Proc; 2007 May; 39(4):1225-7. PubMed ID: 17524939
[TBL] [Abstract][Full Text] [Related]
35. Three-years experience with Neoral C2 monitoring adjusted to a target range of 500-600 ng/ml in long-term renal transplant recipients receiving dual immunosuppressive therapy.
Carstens J
Scand J Urol Nephrol; 2008; 42(3):286-92. PubMed ID: 18432535
[TBL] [Abstract][Full Text] [Related]
36. C2 and C0 values for monitoring cyclosporine therapy in stable heart transplant recipients.
Diciolla F; Scolletta S; Berti L; Maccherini M; Federici D; Bernazzali S; Lisi G; Chiavarelli M
Transplant Proc; 2005 Mar; 37(2):1355-9. PubMed ID: 15848719
[TBL] [Abstract][Full Text] [Related]
37. [C0 vs C2 levels and their implications in kidney transplantation].
Cuero C; Delgado E; de González M; Medina C; Vernaza A; Moscoso J
Rev Med Panama; 2002; 27():30-3. PubMed ID: 16737196
[TBL] [Abstract][Full Text] [Related]
38. Is 3-hour cyclosporine blood level superior to trough level in early post-renal transplantation period?
Mahalati K; Lawen J; Kiberd B; Belitsky P
J Urol; 2000 Jan; 163(1):37-41. PubMed ID: 10604309
[TBL] [Abstract][Full Text] [Related]
39. Study of cyclosporine level at 2 hours after administration in preoperative kidney transplant recipients for prediction of postoperative optimal cyclosporine dose.
Sukhavasharin N; Praditpornsilpa K; Avihingsanon Y; Kuoatawintu P; O-Charoen R; Kansanabuch T; Tungsanga K; Eiam-Ong S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S15-20. PubMed ID: 17044449
[TBL] [Abstract][Full Text] [Related]
40. Effect of cyclosporine therapy with low doses of corticosteroids on idiopathic nephrotic syndrome.
Griveas I; Visvardis G; Papadopoulou D; Nakopolou L; Karanikas E; Gogos K; Stavianoudakis G
Artif Organs; 2010 Mar; 34(3):234-7. PubMed ID: 20447050
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
